Literature DB >> 16896850

Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Pierre Emmanuel Charles1, Frédéric Dalle, Serge Aho, Jean-Pierre Quenot, Jean-Marc Doise, Hervé Aube, Nils-Olivier Olsson, Bernard Blettery.   

Abstract

BACKGROUND: Candidemia is a life-threatening infection in the ICU whose prognosis is highly dependent on the stage at which it is recognized. Procalcitonin (PCT) levels have been shown to accurately distinguish between bacteremia and noninfectious inflammatory states in critically ill patients with clinical signs of sepsis. Little is known about the accuracy of PCT for the diagnosis of candidemia in this setting.
SETTING: A medical intensive care unit in a teaching hospital. PATIENTS AND METHODS: Review of the medical records of every non-neutropenic patient with either bacteremia or candidemia and clinical sepsis in whom PCT dosage at the onset of infection was available between May 2004 and December 2005.
RESULTS: Fifty episodes of either bacteremia (n=35) or candidemia (n=15) were included. PCT levels were found to be markedly higher in patients with bacteremia than in those with candidemia. Moreover, a low PCT value was found to be an independent predictor of candidemia in the study population. According to the calculation of the area under the receiver operating characteristic curve, PCT was found to be accurate in distinguishing between candidemia and bacteremia (0.96 [0.03]). A PCT level of higher than 5.5 ng/ml yields a 100% negative predictive value and a 65.2% positive predictive value for candidemia-related sepsis.
CONCLUSION: A high PCT value in a critically ill non-neutropenic patient with clinical sepsis is unlikely in the setting of candidemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896850     DOI: 10.1007/s00134-006-0306-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

Authors:  G L Petrikkos; S A Christofilopoulou; N K Tentolouris; E A Charvalos; C J Kosmidis; G L Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

2.  Failure of PCT to indicate severe fungal infection in two immunodeficient patients.

Authors:  W Huber; U Schweigart; P Bottermann
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

3.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.

Authors:  B Müller; K L Becker; H Schächinger; P R Rickenbacher; P R Huber; W Zimmerli; R Ritz
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

4.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

5.  Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis.

Authors:  R Wahyuningsih; H J Freisleben; H G Sonntag; P Schnitzler
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

7.  Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

Authors:  Evangelos J Giamarellos-Bourboulis; Anna Mega; Paraskevi Grecka; Nektaria Scarpa; George Koratzanis; George Thomopoulos; Helen Giamarellou
Journal:  Intensive Care Med       Date:  2002-08-07       Impact factor: 17.440

8.  Diagnostic and prognostic value of procalcitonin in patients with septic shock.

Authors:  Christophe Clec'h; Françoise Ferriere; Philippe Karoubi; Jean P Fosse; Michel Cupa; Philippe Hoang; Yves Cohen
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

9.  Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases.

Authors:  Sofia Christofilopoulou; Ekatherina Charvalos; George Petrikkos
Journal:  Eur J Intern Med       Date:  2002-12       Impact factor: 4.487

10.  Candidemia in critically ill patients: difference of outcome between medical and surgical patients.

Authors:  Pierre Emmanuel Charles; Jean Marc Doise; Jean Pierre Quenot; Hervé Aube; Frédéric Dalle; Pascal Chavanet; Nadine Milesi; Ludwig Serge Aho; Henri Portier; Bernard Blettery
Journal:  Intensive Care Med       Date:  2003-09-10       Impact factor: 17.440

View more
  23 in total

Review 1.  [Invasive candidiasis in non-neutropenic adults : Guideline-based management in the intensive care unit].

Authors:  A Glöckner; O A Cornely
Journal:  Anaesthesist       Date:  2013-12       Impact factor: 1.041

2.  Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.

Authors:  Xiaojiong Jia; Congya Li; Ju Cao; Xianan Wu; Liping Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-20       Impact factor: 3.267

3.  Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit.

Authors:  Filippo Pieralli; Lorenzo Corbo; Arianna Torrigiani; Dario Mannini; Elisa Antonielli; Antonio Mancini; Francesco Corradi; Fabio Arena; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli; Gian Maria Rossolini
Journal:  Intern Emerg Med       Date:  2017-02-04       Impact factor: 3.397

4.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

6.  Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis?

Authors:  Pierre Emmanuel Charles; Carmen Castro; Sergio Ruiz-Santana; Cristóbal León; Pedro Saavedra; Estrella Martín
Journal:  Intensive Care Med       Date:  2009-09-16       Impact factor: 17.440

Review 7.  Bloodstream infections in internal medicine.

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

8.  Serum procalcitonin: Early detection of neonatal bacteremia and septicemia in a tertiary healthcare facility.

Authors:  Ibeh Isaiah Nnanna; Osifo John Ehis; Iyere Itoya Sidiquo; Ibeh Georgina Nnanna; Olowe Adekunle
Journal:  N Am J Med Sci       Date:  2011-03

9.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome.

Authors:  Pierre Emmanuel Charles; Claire Tinel; Saber Barbar; Serge Aho; Sébastien Prin; Jean Marc Doise; Nils Olivier Olsson; Bernard Blettery; Jean Pierre Quenot
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

10.  Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report.

Authors:  Pierre Emmanuel Charles; Emmanuel Kus; Serge Aho; Sébastien Prin; Jean-Marc Doise; Nils-Olivier Olsson; Bernard Blettery; Jean-Pierre Quenot
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.